Detalles de la búsqueda
1.
Relationship between lymphocyte count and risk of infection in Japanese rheumatoid arthritis patients treated with tofacitinib.
Mod Rheumatol
; 2024 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38801704
2.
Safety and efficacy of long-term tofacitinib treatment in East Asian patients with ulcerative colitis in OCTAVE Open.
J Gastroenterol Hepatol
; 37(10): 1884-1892, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-35734858
3.
Safety, pharmacokinetics, and preliminary efficacy of the PARP inhibitor talazoparib in Japanese patients with advanced solid tumors: phase 1 study.
Invest New Drugs
; 39(6): 1568-1576, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34160752
4.
Modified- versus immediate-release tofacitinib in Japanese rheumatoid arthritis patients: a randomized, phase III, non-inferiority study.
Rheumatology (Oxford)
; 58(1): 70-79, 2019 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30137547
5.
Efficacy and safety of tofacitinib in Japanese patients with rheumatoid arthritis by background methotrexate dose: A post hoc analysis of clinical trial data.
Mod Rheumatol
; 29(5): 756-766, 2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-30489177
6.
Efficacy and safety of tofacitinib as monotherapy in Japanese patients with active rheumatoid arthritis: a 12-week, randomized, phase 2 study.
Mod Rheumatol
; 25(4): 514-21, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25496464
7.
Long-Term Efficacy and Safety of Lorlatinib in Japanese Patients With ALK-Positive Advanced NSCLC-A Brief Report From the CROWN Study.
JTO Clin Res Rep
; 5(3): 100632, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38434770
8.
A Retrospective, Multicenter, Observational Study to Evaluate Clinical Outcomes of Lorlatinib After Alectinib in Patients With ALK-Positive NSCLC in Japan.
JTO Clin Res Rep
; 4(5): 100508, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-37250506
9.
Efficacy and safety of talazoparib in Japanese patients with germline BRCA-mutated locally advanced or metastatic breast cancer: results of the phase 1 dose-expansion study.
Breast Cancer
; 29(6): 1088-1098, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-35907135
10.
Phase 1 Dose-Escalation Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Tofacitinib in Japanese Healthy Volunteers.
Clin Pharmacol Drug Dev
; 9(1): 11-20, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31713350
11.
Tofacitinib, an oral Janus kinase inhibitor, as monotherapy or with background methotrexate, in Japanese patients with rheumatoid arthritis: an open-label, long-term extension study.
Arthritis Res Ther
; 18: 34, 2016 Jan 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-26818974
12.
Oral tofacitinib efficacy, safety and tolerability in Japanese patients with moderate to severe plaque psoriasis and psoriatic arthritis: A randomized, double-blind, phase 3 study.
J Dermatol
; 43(8): 869-80, 2016 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-26875540
13.
Phase II study of tofacitinib (CP-690,550) combined with methotrexate in patients with rheumatoid arthritis and an inadequate response to methotrexate.
Arthritis Care Res (Hoboken)
; 63(8): 1150-8, 2011 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-21584942
Resultados
1 -
13
de 13
1
Próxima >
>>